Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110806 · ClinicalTrials.gov registry record · NA
Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06110806 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 12 participants.
The verdict
NCT06110806, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This project aims to establish the feasibility and acceptability of a comprehensive mind and body intervention; specifically a mindfulness-based interoceptive exposure (MBIE) for families of youth diagnosed with avoidant/restrictive food intake disorder (ARFID). This project will: (1) explore the feasibility of recruitment, retention, and data collection procedures with youth with ARFID at end of treatment, (2) establish the acceptability and adherence of the MBIE intervention, and (3) evaluate the number of MBIE sessions required to observe changes in the number of foods avoided and mindfulness skills.
Interventions
- BEHAVIORAL MBIE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2024-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06110806
The ClinicalTrials.gov registry entry for NCT06110806 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MBIE is the first listed.
NCT06110806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06110806 about?
NCT06110806 is a clinical study titled "Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder". This project aims to establish the feasibility and acceptability of a comprehensive mind and body intervention; specifically a mindfulness-based interoceptive exposure (MBIE) for families of youth diagnosed with avoidant/restrictive food intake disorder (ARFID). This project will: (1) explore the fe...
What is the current status of trial NCT06110806?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2023-10-17. Estimated completion is 2024-07-08.
What interventions are being tested in trial NCT06110806?
The interventions under investigation include: MBIE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06110806?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.